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lesions in diabetic patients.
METHODS This is a single center, retrospective study. Between July
2008 and April 2013, 74 lesions in 58 diabetic patients were treated
with bare metal stents (BMS group).52 lesions in 42 diabetic patients
were treated with Zilver PTX paclitaxel-eluting nitinol stents (DES
group). We evaluate the clinical outcomes as primary patency,
freedom from re-occlusion, major adverse limb events (MALE) and all-
cause death after endovascular therapy. Stent patency was assessed
by either duplex ultrasound or angiography.
RESULTS Mean follow-up period were 616346 days in BMS group
and 372141 days in DES group. Primary patency at a year was 82%
and 87%. (p¼0.96) freedom from re-occlusion at a year were 92% and
91%. (p¼0.29) Freedom from MALE was 94% and 91%. (p¼0.45) Sur-
vival rate were 86% and 95%. (p¼0.18) Multivariate logistic regression
analysis revealed TASC II class C/D increased the risk of restenosis/
reocclusion with an odds ratio [95% conﬁdence interval] of 3.34
[1.30 to 9.03] (p¼0.01)
CONCLUSION Femoropopliteal stenting for diabetic patients with
drug-eluting stent offers no signiﬁcant advantage over bare metal
stent in middle-term clinical outcome.
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BACKGROUND The reentry failure is one of major causes inﬂuencing
the technical success of endovascular treatment of CTOs in iliac and
femoral arteries. This study was conducted to evaluate the success
rate of reentry during endovascular recanalization of iliac and femoral
CTOs and review the alternative treatment after reentry failure in our
institute.
METHODS This is a retrospective study from prospectively registered
database of patients underwent endovascular treatment for long iliac
artery and femoral artery CTO from October 2008 to September 2014
in Seoul St. Mary hospital and Inha university hospital. The patients
treated with acute thrombotic occlusion and hybrid technique were
excluded. We analyzed the baseline characteristics of patients, suc-
cess rate of reentry, and alternative options after reentry failure.
Initial success rate was deﬁned as a success of recanalization with
initial strategy, overall success rate as total success of recanalization
with initial vascular access and/or alternative endovascular treat-
ment(e.g. using CTO device such as Outback, Truepath, Offroad
etc., or distal vessel puncture (Rendezvous or SAFARI technique) after
failure of initial attempt.
RESULTS Fifty seven iliac CTOs (49 patients) and 19 femoral CTOs (18
patients) were enrolled. Initial success rate was 48 (84.2%) and 11
(57.9%) (p¼.026), and overall success of recanalization was 50 (87.7%)
in iliac CTO group and 16 (84.2%) in femoral CTO group (p¼.704). The
lesions which had angiographic stump, the initial success rate was 39
(90.9%), and the lesions those without stump, the initial success rate
was 64.3% in iliac CTOs (p¼.003), and in femoral CTOs were 71.4 vs.
20% (p¼.111), respectively.CONCLUSION In this study the initial success rate was much higher in
iliac CTOs (84.2%) than in femoral CTOs (57.9%) which was
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increased to 87.7% in iliac CTO group and to 84.2% in femoral CTO
group. His alternative strategies after the initial reentry failure is very
important and can improve overall success rate of endovascular
recanalization of the iliac and femoral CTOs.
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BACKGROUND Endovascular therapy (EVT) have been developed,
however patients with critical limb ischemia (CLI) have a poor prog-
nosis. To evaluate 1 year clinical outcomes after EVT for CLI with
below-the knee (BK) disease from daily practice.
METHODS Between 2011 July and 2013 July, 40 patients with CLI were
treated BK interventions. We investigated the occurrence of clinical
events within 12 months after EVT, such as death, major and minor
amputation, and revascularization.
RESULTS Of these patients, mean age was 75.08.2 years, 52.5% (21/
40) was male. Rutherford class 4 was 8 patients, 5 was 30 patients and
6 was 2 patients. Hypertensive patients were 33(82.5%), Dyslipidemia
were 16 (40%). Diabetes were 30 (75%), Hyperuricemia were 5 (12.5%),
prior and current smoker were 19 (47.5%) and Hemodialysis patients
were 9 (22.5%). 12 months after EVT (follow up % was 95%), there
were 2 deaths (8.3%), 0 major amputation (0%), 6 minor amputations
(25.0%). 33.3% of all patients were needed revascularizations.
CONCLUSION 1 year clinical outcomes after endovascular therapy for
critical limb ischemia with below-the knee disease were acceptable in
our hospital.
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BACKGROUND Acute mesenteric ischemia carries high morbidity and
mortality rates unless urgently treated. In patients without evident
bowel necrosis on computer tomography, the treatment remained
conservative in less experienced hospital. When a suspicious case
progressed into septic shock, the patient was usually too ill to receive
deﬁnitive surgical management. Unless an early invasive angiography
strategy was adopted, it is sometimes difﬁcult to establish deﬁnitive
diagnosis in early cases without signs of bowel necrosis. Hence, we
developed a protocol-driven strategy to improve deﬁnitive diagnosis,
endovascular salvage, and survival rates. We aim to report our two-
year results with this protocol-driven strategy.
METHODS We developed a protocol for patients with clinically sus-
pected acute mesenteric ischemia visiting the emergency room in a
rural hospital. Patients who presented with acute abdominal pain with
suspicious mesenteric ischemia by contrast CT study were enrolled
and prospectively followed. The inclusion criteria were: 1. emergency
room visit for acute abdominal pain or shock with elevated lactate
level, 2. suspected thrombus formation or decreased ﬂow in one of
the mesenteric vessels. The exclusion criteria were: 1. deﬁnitive
pathology other than ischemia found by CT and 2. Bowel necrosis
mandating surgical exploration. A dedicated gastroenterologist, an
interventional radiologist, two interventional cardiologists, and two
general surgeons were invited to provide clinical judgment whether
early invasive strategy is justiﬁed when no bowel necrosis signs were
found by CT. We prospectively collected angiography ﬁndings,
treatment results, complications, and survival rates of conﬁrmed
acute mesenteric ischemia. The primary outcome was survival in
conﬁrmed cases.
RESULTS From August, 2012 to August, 2014, total 1916 contrast-
enhanced abdominal computer tomography was performed in our
emergency room for acute abdominal pain. Eight patients fulﬁlled the
inclusion criteria. All enrolled patients proceed to complete the pro-
tocol of early invasive strategy. All had acute mesenteric ischemia
conﬁrmed by selective angiography. Endovascular salvage with
equipment used in primary percutaneous coronary intervention for
ST-elevation myocardial infarction was attempted. The angiographicsuccess rate was 100% in non-calciﬁed cases (6/8), but 0% in heavily
calciﬁed and high thrombus burden cases (2/8). The 30-day survival
rate was 100% in angiographic success patients and 0% in failed cases.
No procedure-related complication was noted. Five survived patients
were discharged within very short ICU stay (less than 48 hours) and
appeared well up to 90-day follow-up.
CONCLUSION In patients with suspected acute mesenteric ischemia,
a protocol-driven approach with early invasive strategy improved
patient outcome with acceptable safety and feasibility.TCTAP A-104
Randomized Comparison of Vascular Healing Response Between Self-
Expanding Nitinol Stent and Self-Expanding Paclitaxel-Eluting Stent in the
Superﬁcial Femoral Artery: An Optical Frequency Domain Imaging Study
Kojiro Miki,1 Kenichi Fujii,1 Masashi Fukunaga,1 Masaharu Ishihara2
1Hyogo College of Medicine, Japan; 2National Cerebral and
Cardiovascular Center, Japan
BACKGROUND Similar to the coronary artery, late stent thrombosis
(ST) due to delayed vascular healing is concerned after drug-eluting
stent (DES) implantation in the superﬁcial femoral artery (SFA).
Therefore, we analyzed vascular response after DES implantation in
the SFA with optical frequency domain imaging (OFDI).
METHODS Consecutive 34 de novo SFA lesions from 30 patients un-
derwent endovascular therapy (EVT) were randomly assigned 1:1 to
receive self-expanding bare-metal nitinol stent (BMS, 17 lesions)
or self-expanding paclitaxel-eluting nitinol stent (PES, 17 lesions)
implantation. Six months after initial EVT, follow-up angiography
and OFDI examination were conducted to evaluate the vascular
response to the stents. OFDI analyses were performed at 5-mm axial
intervals throughout entire stented segments. Neointimal tissue (NIT)
thickness inside all stent struts was measured. In the morphological
OFDI analysis, the presence of thrombus, microvessels, peri-strut low
intensity area (PLIA), and the optical appearance of NIT were
analyzed. The optical appearance of NIT was classiﬁed into 3 patterns:
homogeneous, layered, and heterogeneous patterns. The primary
end-point was the percentage of uncovered stent strut at 6-month
follow-up.
RESULTS The mean lesion length was 79  46 mm. During follow-up
period, 3 patients died, 2 patients refused follow-up examination, and
2 lesions were performed revascularization for restenoses of target
lesions. Finally, follow-up angiography and OFDI were performed in
27 lesions and 12547 stent struts were analyzed. The binary angio-
graphic restenosis rate at 6-month follow-up was 21.4% in BMS group
and 7.7% in PES group (p¼0.60). The percentage of uncovered strut
was higher in PES group compared to BMS group (15.2% vs. 2.6%,
p<0.01). Mean NIT thickness was smaller in PES group (426  144 mm
vs. 650  165 mm, p<0.01). Prevalence of thrombus, microvessels, and
PLIA were similar between two groups. Also, there was no signiﬁcant
difference in the optical appearance of NIT.
CONCLUSION OFDI revealed that vascular healing after DES im-
plantation in the SFA was impaired at chronic phase. An adjunc-
tive therapy might be required for prevention of ST after DES
implantation.
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BACKGROUND Cardio vascular interventional procedures are still
often performed through femoral artery access. Manual compression
to the femoral artery is a traditionally method of hemostasis after
procedure, but its long time to ambulation and inadequate hemostasis
often occurred the complications included major hematoma,
bleeding, arteriovenous ﬁstula and deep venous thrombosis. Vascular
closure devices (VCDs) are increasing used after various types of
cardiovascular procedures including coronary, cerebrovascular and
peripheral arterial intervention. And several types of VCDs have
become available to the management of access site after those pro-
cedures. EXOSEAL VCD device is a bioabsorbable device designed for
the sealing of femoral artery puncture site and has a visually guided
deployment mechanism that delivers a bioabsorbable poly-glycolic
acid plug atop of femoral artery. The aim of this study was to assess
the safety and efﬁcacy of an Exoseal VCD device for achievement of
